Journal of Clinical Nephrology and Therapeutics

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.
Reach Us +1 (202) 780-3397

Brief Report - Journal of Clinical Nephrology and Therapeutics (2024) Volume 8, Issue 2

Nephrotic Syndrome: Understanding the Condition, its Causes, Symptoms, and Treatment

Jingyu Xin*

Department of Prevention and Health Care, Baogang Hospital, China

*Corresponding Author:
Jingyu Xin
Department of Prevention and Health Care, Baogang Hospital, China
Baogang Hospital
China
E-mail:jingyu@xin.cn

Received:29-Mar-2024,Manuscript No. AACNT-24-135424; Editor assigned:04-Apr-2024,PreQC No. AACNT-24-135424(PQ); Reviewed:18-Apr-2024,QC No. AACNT-24-135424; Revised:22-Apr-2024,Manuscript No. AACNT-24-135424(R); Published: 28-Apr-2024,DOI: 10.35841/ aacnt-8.2.194

Citation: Xin J. Nephrotic syndrome: Understanding the condition, its causes, symptoms, and treatment. J Clin Nephrol Ther. 2024;8(2):194

Visit for more related articles at Journal of Clinical Nephrology and Therapeutics

Introduction

Nephrotic syndrome is a complex kidney disorder characterized by the presence of high levels of protein in the urine, low levels of protein in the blood, swelling (edema), and high cholesterol. This syndrome can be caused by various underlying conditions that affect the kidneys' filtering units, known as the glomeruli. Understanding the intricacies of nephrotic syndrome is crucial for early diagnosis and effective management. Nephrotic syndrome is a kidney disorder characterized by the presence of high levels of protein in the urine, low levels of protein in the blood, swelling (edema), and high cholesterol.[1].

This syndrome can be caused by various underlying conditions that affect the glomeruli, the kidney's filtering units. Understanding the complexities of nephrotic syndrome is crucial for early detection and effective management. This article provides an overview of nephrotic syndrome, including its causes, symptoms, and treatment options. It also highlights the importance of early diagnosis and ongoing monitoring to prevent complications and preserve kidney function in individuals with this condition.[2].

Nephrotic syndrome is not a single disease but rather a set of signs and symptoms that indicate kidney damage. The primary function of the kidneys is to filter waste and excess fluids from the blood, while keeping essential proteins and other nutrients in the bloodstream. In nephrotic syndrome, damage to the glomeruli causes them to become more permeable, allowing large amounts of protein to leak into the urine.[3].

Minimal Change Disease: A type of kidney disease most commonly seen in children, where the kidney's filters appear normal under a microscope but do not function properly.A condition where the glomeruli become thickened and inflamed, leading to increased protein leakage.A condition that causes scarring in the glomeruli, leading to proteinuria and other symptoms of nephrotic syndrome.[4].

Kidney damage caused by diabetes, which can lead to nephrotic syndrome and eventually, kidney failure.An autoimmune disease that can affect many parts of the body, including the kidneys, leading to nephrotic syndrome.Medications: Including corticosteroids, immunosuppressants, and diuretics to reduce inflammation, suppress the immune system, and manage fluid retention.[5].

Dietary Changes: Including reducing salt intake and limiting protein, potassium, and phosphorus to help manage edema and maintain kidney function.Management of Underlying Conditions: Treating underlying conditions such as diabetes or lupus to help improve kidney function and reduce proteinuria.[6].

Understanding nephrotic syndrome is essential for healthcare professionals involved in the care of patients with kidney disorders. This article provides a comprehensive overview of nephrotic syndrome, including its causes, symptoms, and treatment options. By understanding the complexities of this condition, healthcare professionals can provide better care and improve outcomes for patients with nephrotic syndrome.Nephrotic syndrome is characterized by abnormalities in the glomerular filtration barrier, which consists of the endothelial cells, basement membrane, and podocytes. Damage to this barrier leads to increased permeability to proteins, resulting in proteinuria. The exact mechanisms underlying this damage vary depending on the underlying cause of nephrotic syndromeMinimal Change Disease (MCD): In MCD, there is a disturbance in T cell function, leading to the release of cytokines that damage the glomerular epithelial cells (podocytes). This damage results in increased permeability of the glomerular filtration barrier to proteins.Membranous Nephropathy: Membranous nephropathy is characterized by the formation of immune complexes, primarily containing antibodies against phospholipase A2 receptor (PLA2R) or thrombospondin type-1 domain-containing 7A (THSD7A), which deposit in the glomerular basement membrane. This deposition triggers an inflammatory response and complement activation, leading to podocyte injury and proteinuria.[7].

Minimal Change Disease (MCD): In MCD, there is a disturbance in T cell function, leading to the release of cytokines that damage the glomerular epithelial cells (podocytes). This damage results in increased permeability of the glomerular filtration barrier to proteins.Membranous Nephropathy: Membranous nephropathy is characterized by the formation of immune complexes, primarily containing antibodies against phospholipase A2 receptor (PLA2R) or thrombospondin type-1 domain-containing 7A (THSD7A), which deposit in the glomerular basement membrane. This deposition triggers an inflammatory response and complement activation, leading to podocyte injury and proteinuria [8].

.

Focal Segmental Glomerulosclerosis (FSGS): FSGS is characterized by the presence of scar tissue in the glomeruli, which disrupts the filtration barrier. The exact cause of FSGS is not well understood, but it is believed to involve genetic predisposition, immune system abnormalities, and circulating factors that injure podocytes.Diabetic Nephropathy: In diabetic nephropathy, high blood glucose levels lead to the production of advanced glycation end products (AGEs), which accumulate in the glomeruli and promote inflammation and fibrosis. This damage results in increased permeability of the glomerular filtration barrier.The hallmark features of nephrotic syndrome include proteinuria (>3.5 grams per day), hypoalbuminemia, edema, and hyperlipidemia. [9]

.

Patients may also experience fatigue, loss of appetite, and foamy urine. Diagnosis is based on clinical features, urine dipstick testing for proteinuria, serum albumin levels, lipid profile, and renal biopsy in some cases to determine the underlying cause.Treatment of nephrotic syndrome aims to reduce proteinuria, control edema, and prevent complications. Initial treatment for MCD and some cases of FSGS, aimed at reducing inflammation and proteinuria. Immunosuppressive Agents: Used in cases of steroid-resistant nephrotic syndrome or membranous nephropathy, to suppress the immune system and reduce proteinuria.Dietary Modifications: Including reducing salt intake and limiting protein and fat to manage edema and hyperlipidemia. Control of Underlying Conditions: Such as diabetes or lupus, to improve kidney function and reduce proteinuria. In cases where conservative measures are ineffective, or if there is progressive kidney damage, renal replacement therapy, such as hemodialysis or kidney transplantation, may be necessary [10]

.

Conclusion

Nephrotic syndrome is a complex kidney disorder that requires careful management to prevent complications and preserve kidney function. Early diagnosis, treatment, and ongoing monitoring are essential for individuals with this condition. By understanding the causes, symptoms, and treatment options for nephrotic syndrome, healthcare professionals can provide better care and improve outcomes for patients affected by this challenging condition. In conclusion, nephrotic syndrome is a complex kidney disorder with diverse underlying causes. Understanding the pathophysiology, clinical presentation, and management strategies is essential for healthcare professionals involved in the care of patients with this condition. By implementing appropriate treatment strategies, healthcare providers can improve outcomes and quality of life for patients with nephrotic syndrome..

References

References

  1. Sigmund M, Ferstl R. Panel vector autoregression in R with the package panelvar. Q Rev Econ Finance. 2021; 80:693-720.

    2. Indexed at, Google scholar

     

  2. Yang X, Le Minh H, Cheng KT, et al. Renal compartment segmentation in DCE-MRI images. Med Image Anal. 2016;32:269-80.

    3. Indexed at, Google scholar, Cross ref

     

  3. Bhutani H, Smith V, Rahbari-Oskoui F, et al. A comparison of ultrasound and magnetic resonance imaging shows that kidney length predicts chronic kidney disease in autosomal dominant polycystic kidney disease. Kidney int. 2015;88(1):146-51.

    4. Indexed at, Google scholar, Cross ref

     

  4. Kistler AD, Poster D, Krauer F, et al. Increases in kidney volume in autosomal dominant polycystic kidney disease can be detected within 6 months. Kidney int. 2009;75(2):235-41.

    5. Indexed at, Google scholar, Cross ref

     

  5. Cardenas CE, Yang J, Anderson BM, et al. Advances in auto-segmentation. Semin radiat oncol. 2019;29(3): 185-197.

    6. Indexed at, Google scholar, Cross ref

  6. Chapman AB, Devuyst O, Eckardt KU, et al. Autosomal-dominant polycystic kidney disease (ADPKD): Executive summary from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. Kidney Int. 2015;88(1):17-27.

    7. Indexed at, Google scholar, Cross ref

     

  7. Kistler AD, Poster D, Krauer F, et al. Increases in kidney volume in autosomal dominant polycystic kidney disease can be detected within 6 months. Kidney int. 2009;75(2):235-41.

    8. Indexed at, Google scholar, Cross ref

     

  8. Bhutani H, Smith V, Rahbari-Oskoui F, et al. A comparison of ultrasound and magnetic resonance imaging shows that kidney length predicts chronic kidney disease in autosomal dominant polycystic kidney disease. Kidney int. 2015;88(1):146-51.

    9. Indexed at, Google scholar, Cross ref

     

  9. Momeny M, Neshat AA, Hussain MA, et al . Learning-to-augment strategy using noisy and denoised data: Improving generalizability of deep CNN for the detection of COVID-19 in X-ray images. Comput Biol Med. 2021;136:104704.

    10. Indexed at, Google scholar , Cross ref

     

  10. Sigmund M, Ferstl R. Panel vector autoregression in R with the package panelvar. Q Rev Econ Finance. 2021; 80:693-720.

    11. Indexed at, Google scholar

Get the App